| __timestamp | AstraZeneca PLC | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 4101058 |
| Thursday, January 1, 2015 | 5997000000 | 10763215 |
| Friday, January 1, 2016 | 5890000000 | 5579049 |
| Sunday, January 1, 2017 | 5757000000 | 32051299 |
| Monday, January 1, 2018 | 5932000000 | 24482286 |
| Tuesday, January 1, 2019 | 5958000000 | 43892589 |
| Wednesday, January 1, 2020 | 5991000000 | 44505000 |
| Friday, January 1, 2021 | 9736000000 | 79406000 |
| Saturday, January 1, 2022 | 9762000000 | 49283000 |
| Sunday, January 1, 2023 | 10935000000 | 17282730 |
| Monday, January 1, 2024 | 13583000000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, AstraZeneca PLC has consistently outpaced Verona Pharma plc in R&D investment. From 2014 to 2023, AstraZeneca's R&D expenses surged by nearly 96%, peaking at approximately $10.9 billion in 2023. In contrast, Verona Pharma's R&D spending, while growing, reached a modest $17.3 million in the same year. This stark difference highlights AstraZeneca's strategic focus on pioneering new treatments and maintaining its market leadership. Meanwhile, Verona Pharma's steady increase in R&D investment, despite being significantly lower, underscores its dedication to carving out a niche in the industry. As the pharmaceutical sector continues to evolve, these investments will play a pivotal role in shaping the future of healthcare.
Research and Development Expenses Breakdown: AstraZeneca PLC vs Zoetis Inc.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Verona Pharma plc
Takeda Pharmaceutical Company Limited or Verona Pharma plc: Who Invests More in Innovation?
R&D Spending Showdown: Bio-Techne Corporation vs Verona Pharma plc
Analyzing R&D Budgets: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Research and Development Investment: Verona Pharma plc vs CymaBay Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How Verona Pharma plc and MannKind Corporation Allocate Funds